A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

Clinical trial NCT05523167 · COMPLETED

Trial details

NCT number: NCT05523167
Sponsor: argenx
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Active Idiopathic Inflammatory Myopathy Myositis Dermatomyositis Polymyositis Immune-Mediated Necrotizing Myopathy Antisynthetase Syndrome

Start date: 2022-10-12
Primary completion: 2026-07-02
Enrollment: 265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.